Antiviral activity of Bacillus sp. isolated from the marine sponge petromica citrina against bovine viral diarrhea virus, a surrogate model of the hepatitis C virus

Viruses

Volumn 5, Issue 5, 2013, Pages 1219-1230

  Santiago Bastos, Juliana Cristina ^a   Konecny Kohn, Luciana ^a   Fantinatti Garboggini, Fabiana ^a   Aiello Padilla, Marina ^a   Furtado Flores, Eduardo ^b   da Silva, Bárbara Pereira ^a   de Menezes, Cláudia Beatriz Afonso ^a   Weis Arns, Clarice ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antiviral agents; Hepatitis C virus; Marine microorganisms

Indexed keywords

BACILLUS EXTRACT; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACILLUS; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CONTROLLED STUDY; DRUG MECHANISM; HEPATITIS C VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PETROMICA CITRINA; SPONGE (PORIFERA); VIRUS ATTACHMENT;

ANIMALS; ANTIVIRAL AGENTS; BACILLUS; CATTLE; CELL LINE; DIARRHEA VIRUS 1, BOVINE VIRAL; DNA, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PORIFERA; SEQUENCE ANALYSIS, DNA; VIRUS ATTACHMENT;

BACILLUS SP.; BOVINE VIRAL DIARRHEA VIRUS 1; HEPATITIS C VIRUS; INVERTEBRATA;

EID: 84876925732     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5051219     Document Type: Article

References (36)

1. Yasuhara-Bell, J.; Yang, Y.; Barlow, R.; Trapido-Rosental, H.; Lu, Y. In vitro evaluation of marine microorganism extracts for antiviral activity. Virol. J. 2010, 7, 182.
2. Ravikumar, Y.S.; Upasana, R.; Nandhitha, M.; Perween, A.; Naika, H.R. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as a potent natural source. Virus Res. 2011, 158, 89-97.
3. Li, H.; Stoddard, M.B.; Wang, S.; Blair, L.M.; Giorgi, E.E. Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome sequencing. PLoS Pathog. 2012, 8, e1002880.
4. Suzuki, T.; Ishii, K.; Aizaki, H.; Wakita, T. Hepatitis C viral life cycle. Adv. Drug Del. Rev. 2007, 59, 1200-1212.
5. Barnes, E.; Folgori, A.; Capone, S.; Swadling, L.; Aston, S.; Kurioka, A.; Meyer, J.; Huddart, R.; Smith, K.; Townsend, R.; Brown, A.; Antrobus, R.; Ammendola, V.; Naddeo, M.; O'Hara, G.; Willberg, C.; Harrison, A.; Grazioli, F.; Esposito, M.L.; Siani, L.; Traboni, C.; Oo, Y.; Adams, D.; Hill, A.; Colloca, S.; Nicosia, A.; Cortese, R.; Klenerman, P. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. SciTransl Med. 2012, 4, 115ra1. doi:10.1126/scitranslmed.3003155.
6. Sako, K.; Aoyama, H.; Sato, S.; Hashimoto, Y.; Baba, M. γ-Carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity. Bioorg. Med. Chem. 2008, 16, 3780-3790.
7. Martinot-Peignoux, M.; Boyer, N.; Pouteau, M.; Castelnau, C.; Giuily, N.; Duchatelle, V.; Aupérin, A.; Degott, C.; Benhamou, J.P.; Erlinger, S. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J. Hepatol. 1998, 29, 214-223.
8. Lemon, S.M.; McKeating, J.A.; Pietschmann, T.; Frick, D.N.; Glenn, J.S.; Tellinghuisen, T.L.; Symons, J.; Furman, P.A. Development of novel therapies for hepatitis C. Antiviral Res. 2010, 86, 79-92.
9. Duverlie, G.; Wychowski, C. Cell culture systems for the hepatitis C virus. J. Gastroenterol. 2007, 13, 2442-2445.
10. Finkielsztein, L.M.; Moltrasio, G.Y.; Caputto, M.E.; Castro, E.F.; Cavallaro, L.V.; Moglioni, A.G. What is known about the antiviral agents active against bovine viral diarrhea virus (BVDV)? Curr. Med. Chem. 2010, 17, 2933-2955.
11. Buckwold, V.E.; Beer, B.E.; Donis, R.O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 2003, 60, 1-15.
12. Zitzmann, N.; Mehta, A.S.; Carrouee, S.; Butters, T.D.; Platt, F.M.; McCauley, J.; Blumberg, B.S.; Dwek, R.A.; Block, T.M. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a Pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. 1999, 96, 11878-11882.
13. Baginski, S.G.; Pevear, D.C.; Seipel, M.; Sun, S.C.; Benetatos, C.A.; Chunduru, S.K.; Rice, C.M.; Collett, M.S. Mechanism of action of a pestivirus antiviral compound. Proc. Natl. Acad. Sci. 2000, 97, 7981-7986.
14. Buckwold, V.E.; Wei, J.; Wenzel-Mathers, M.; Russell, J. Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication. Antimicrobial. Agents Chemother. 2003, 47, 2293-2298.
15. Yanagida, K.; Baba, C.; Baba, M. Inhibition of bovine viral diarrhea virus (BVDV) by mizoribine: synergistic effect of combination with interferon-α. Antiviral Res. 2004, 64, 195-201.
16. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immun. Meth. 1983, 65, 55-63.
17. Scudiero, D.A.; Shoemaker, R.H.; Paull, K.D. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988, 48, 4827-4833.
18. Reed, L.J.; Münch, H.A. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27, 493-497.
19. Takeuchi, H.; Baba, M.; Shigeta, S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J. Virol. Methods. 1991, 33, 61-71.
20. Koseki, I.; Simoni, I.C.; Nakamura, I.T.; Noronha, A.B.; Costa, S.S. Antiviral activity of plant extracts against aphtovirus, pseudorabiesvírus and pestivirus in cell cultures. Microbios. Letters. 1990, 44, 19-30.
21. Pospiech, A.; Neumann, B. A versatile quick-prep of genomic DNA from Gram-positive bacteria. Trends Genetics 1995, 11, 217-218.
22. Lane, D.J.; Pace, B.; Olsen, G.J.; Stahl, D.A.; Sogin, M.L.; Pace, N.R. Rapid determination of 16S ribosomal RNA sequences for phylogenetic analysis. Proc. Nat. Acad. Sci. 1985, 82, 6955-6959.
23. Menezes, C.B.A.; Bonugli-Santos, R.C.; Miqueletto, P.B.; Passarini, M.R.Z.; Silva, C.H.D.; Justo, M.R.; Rebeca, R.; Fantinatti-Garboggini, F.; Oliveira, V.M.; Berlinck, R.G.S.; Sette, L.D. Microbial diversity associated with algae, ascidians and sponges from the north coast of São Paulo state, Brazil. Microbiol. Res. 2010, 165, 466-482.
24. Costa-Lotufo, L.V.; Wilke, D.V.; Jimenez, P.C.; Epifanio, R.A. Organismos marinhos como fonte de novos fármacos: Histórico & perspectivas. Quim. Nova. 2009, 32, 703-716.
25. Laport, M.S.; Santos, O.C.; Muricy, G. Marine sponges: potential sources of new antimicrobial drugs. Curr. Pharm. Biotechnol. 2009, 10, 86-105.
26. Marinho, P.R.; Muricy, G.R.S.; Silva, M.F.L.; de Marval, M.G.; Laport, M.S. Antibiotic-resistant bacteria inhibited by extracts and fractions from Brazilian marine sponges. Brazilian J. Pharmac. 2010, 20, 267-275.
27. Donadio, S.; Monciardini, P.; Sosio, M. Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat. Prod. Rep. 2007, 24, 1073-1109.
28. Mikhaǐlova, N.A.; Nagieva, F.G.; Grin'ko, O.M.; Zverev, V.V. Experimental study of antiviral activity of spore-forming bacterium Bacillus pumilus "Pashkov". Mikrobiol. Epidemiol. Immunobiol. 2010, 2, 69-74.
29. Gribencha, S.V.; Potselueva, L.A.; Barinskiǐ, I.F.; Deev, S.M.; Balandin, T.G.; Leshchinskaia, I.B. Antiviral activity of Bacillus intermedius RNAase in guinea-pigs and rabbits infected with outdoor rabies virus. Vopr. Virusol. 2006, 51, 41-43.
30. Gribencha, S.V.; Potselueva, L.A.; Barinskiǐ, I.F.; Balandin, T.G.; Deev, S.M.; Leshchinskaia, I.B. The antiviral activity of RNAse Bacillus intermedius in experiments with mice preinfected with street rabies virus. Vopr. Virusol. 2004, 49, 38-41.
31. Zhou, W.W.; Niu, T.G. Purification and some properties of an extracellular ribonuclease with antiviral activity against tobacco mosaic virus from Bacillus cereus. Biotechnol. Lett. 2009, 31, 101-105.
32. Boya, C.A.; Herrera, L.; Guzman, H.M.; Gutierrez, M. Antiplasmodial activity of bacilosarcinA isolated from the octocoral-associated bacterium Bacillus sp. collected in Panama. J. Pharm. Bioallied. Sci. 2012, 4, 66-69.
33. El-Sersy, N.A.; Abdelwahab, A.E.; Abouelkhiir, S.S. Antibacterial and anticancer activity of ε-poly-L-lysine (ε-PL) produced by a marine Bacillus subtilis sp. J. Basic Microbiol. 2012, 52, 513-522.
34. Craczyc, K.; Trojanowska, K.; Mueller, A. Antifungal activity of Bacillus coagulans against Fusarium sp. Acta Microbiol. Pol. 2002, 51, 275-283.
35. Sohn, M.J.; Zheng, C.J.; Kim, W.G. Macrolactin S, a new antibacterial agent with FabG-inhibitory activity from Bacillus sp. AT28. J. Antibiot. 2008, 61, 687-691.
36. Moshafi, M.H.; Forootanfar, H.; Ameri, A. Antimicrobial activity of Bacillus sp. strain FAS1 isolated from soil. Pak. J. Pharm. Sci. 2011, 24, 269-275.